34
J. P. Burke et al. / Tetrahedron: Asymmetry 22 (2011) 31–35
OH
CO2Me
O
MeO2C
MeO2C
OAc
DMP,
O
CH2Cl2
(60%)
H
OAc
18
OAc
17
exo-19
Scheme 6. Formation and exo-selective IMDA reaction of acrylate 18.27
ꢁ1.5:1 mixture of diastereomers (69 mg, 18%). The resulting dia-
stereomeric mixture of alcohols (56 mg, 0.15 mmol) was allowed
to stir with Dess–Martin periodinane23 (96 mg, 0.23 mmol) in
CH2Cl2 (2 mL) at rt for 4 h. The reaction was diluted with CH2Cl2
(3 mL) and washed sequentially with satd NaHCO3 (5 mL), satd
Na2S2O3 (5 mL), and brine (5 ml) before drying (MgSO4) and con-
centrating to a yellow oil (50 mg, 91%). A solution of the crude tri-
ene 822 (50 mg, 0.13 mmol) in toluene (2 mL, 0.07 M) was heated
at 140 °C in a sealed tube for 15 h. 1H NMR analysis of the crude
reaction showed two products in a ꢁ4:1 ratio (d, 0.77 and
0.44 ppm). The residue was purified by flash column chromatogra-
phy (30% EtOAc/Hex) to afford lactone (ꢀ)-16 as an ivory solid
(19 mg, 38%): Rf (30% EtOAc/hexanes) = 0.31; 1H NMR (500 MHz,
CDCl3) d 6.37 (s, 3H), 5.84 (ddd, J = 9.9, 5.1, 2.5 Hz, 1H), 5.49 (dd,
J = 10.0, 1.7 Hz, 1H), 4.41 (dd, J = 12.0, 9.1 Hz, 1H), 3.94 (dd,
J = 12.0, 10.5 Hz, 1H), 3.81 (s, 6H), 3.17–3.05 (m, 2H), 2.71 (dt,
J = 12.5, 5.5 Hz, 1H), 2.64 (dd, J = 9.4, 1.8 Hz, 1H), 2.53 (ddd,
J = 13.2, 5.2, 3.8 Hz, 1H), 2.37–2.28 (m, 1H), 2.18–2.09 (m, 2H,),
1.85–1.67 (m, 2H), 0.78 (d, J = 7.2 Hz, 3H); 13C NMR (CDCl3,
125 MHz) d 210.6, 171.8, 161.0, 144.7, 129.0, 128.2, 106.9, 98.0,
69.9, 62.5, 55.3, 48.7, 42.8, 40.9, 39.8, 30.0, 29.9, 26.2, 18.5; IR
(cmꢀ1) 3054, 2918, 2848, 1749, 1699, 1595, 1460, 1315, 1265,
3. Conclusion
In conclusion while the stereoconfiguration of tricycle (ꢀ)-16
does not match that of (+)-1, it does correlate to the absolute
stereoconfiguration of the minor IMDA products (ꢀ)-6b and 6c
obtained in our previous studies.7 Therefore, constraining the C-2
stereogenic center within the lactone affords a complete reversal
of
p-facial selectivity without obviating the overlap between the
ketone carbonyl and diene in the transition state. Accordingly,
we now have two alternative strategies to directly access stereo-
chemical analogs of (+)-symbioimine. We intend to employ these
valuable molecular tools to explore the structure–activity relation-
ship of the unique anti-osteoclastogenic alkaloid.
4. Experimental
4.1. (R)-5-Methyl-5,6-dihydro-2H-pyran-2-one (ꢀ)-9
At first, n-BuLi (1.6 M in hexanes, 6.2 mL, 9.97 mmol) was added
dropwise to distilled diisopropylamine (1.01 g, 9.97 mmol) in THF
(10 mL) at ꢀ30 °C and let stir 15 min before cooling to ꢀ78 °C and
adding dry EtOAc (0.97 mL, 9.97 mmol) dropwise. After stirring for
1 h at ꢀ78 °C, (2S)-2-methyl-3-(tetrahydro-2H-pyran-2-yloxy)-
propan-al14 (1.56 g, 9.05 mmol) in THF (10 mL) was added drop-
wise. The reaction mixture was stirred 30 min at ꢀ78 °C and then
quenched with satd NH4Cl (20 mL) before extracting with CH2Cl2
(2 ꢂ 20 mL), drying (MgSO4), and concentrating to a partially solid-
ified oil (1.95 g, 83%). Benzene and p-TsOHꢃH2O (1.71 g, 8.99 mmol)
were then added to the crude product and the mixture was heated
at reflux (Dean–Stark) for 7 h. The reaction mixture was diluted
with satd NaHCO3 (20 mL) and the resulting organic layer was
washed sequentially with H2O (20 mL) and brine (20 mL), dried
(MgSO4), and concentrated to a black residue before distillation
using a Kugelrohr apparatus (1 torr, 90–110 °C) to collect a clear
colorless oil (0.78 g, 92%): Rf = 0.27 (30% EtOAc/hexanes); 1H
NMR (300 MHz, CDCl3) d 6.78 (ddd, J = 9.8, 3.5, 0.7 Hz, 1H), 5.93
(dd, J = 9.8, 2.0 Hz, 1H), 4.37 (ddd, J = 11.0, 5.0, 1.1 Hz, 1H), 4.03
(dd, J = 11.0, 8.3 Hz, 1H), 2.72–2.59 (m, 1H), 1.11 (d, J = 7.2 Hz,
3H); 13C NMR (CDCl3, 75 MHz) d 163.6, 151.5, 120.0, 72.0, 28.7,
1158; ½a 2D3
¼ ꢀ119:8 (c 0.40, CHCl3); HRMS (ES+) m/z 393.1666
ꢄ
[(M+Na)+; calculated for C22H26O5Na+: 393.1673]. A crystal suit-
able for X-ray analysis was obtained by slow evaporation from
EtOAc/Hex; mp = 42–45 °C.25,26
Acknowledgments
Partial financial support provided by the UVA Institute on Aging
(UVA) and the NSF [CHE-0320669 (UR)]. J.P.B. was supported by a
Presidential Fellowship from the UVA GSA&S.
References
1. Roush, W. R. In Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon
Press: Oxford, 1992; Vol. 5, p 513.
2. Recent examples: (a) Spangler, J. E.; Sorensen, E. J. Tetrahedron 2009, 65, 6739;
(b) Miller, K. A.; Tsukamoto, S.; Williams, R. M. Nat. Chem. 2009, 1, 63; (c)
Nicolaou, K. C.; Toh, Q. Y.; Chen, D. Y. K. J. Am. Chem. Soc. 2008, 130, 11292; (d)
Miller, K. A.; Welch, T. R.; Greshock, T. J.; Ding, Y. S.; Sherman, D. H.; Williams,
R. M. J. Org. Chem. 2008, 73, 3116.
3. For recent examples and reviews see: (a) Tantillo, D. J. Org. Lett. 2010, 12, 1164;
(b) Kelly, W. L. Org. Biomol. Chem. 2008, 6, 4483; (c) Miller, K. A.; Williams, R. M.
Chem. Soc. Rev. 2009, 38, 3160; (d) Williams, R. M. Chem. Pharm. Bull. 2002, 50,
711; (e) Tsukamoto, S.; Kawabata, T.; Kato, H.; Greshock, T. J.; Hirota, H.; Ohta,
T.; Williams, R. M. Org. Lett. 2009, 11, 1297.
15.3; ½a 2D3
¼ ꢀ42:0 (c 1.0, CHCl3); HRMS (ES+) m/z 135.0425
ꢄ
[(M+Na)+; calcd for C6H8NaO2þ: 135.0417].
4.2. Tricyclic lactone (ꢀ)-16
4. (a) Kita, M.; Konda, M.; Koyama, T.; Yamada, K.; Matsumoto, T.; Lee, K.; Woo, J.;
Uemura, D. J. Am. Chem. Soc. 2004, 125, 4794; (b) Kita, M.; Ohishi, N.; Washida,
K.; Kondo, M.; Koyama, T.; Yamada, K.; Uemura, D. Bioorg. Med. Chem. 2005, 13,
5253.
5. (a) Zou, Y.; Che, Q.; Snider, B. B. Org. Lett. 2006, 8, 5605; (b) Snider, B. B.; Che, Q.
Angew. Chem., Int. Ed. 2006, 45, 932; (c) Kim, J.; Thomson, R. J. Angew. Chem., Int.
Ed. 2007, 46, 3104.
6. Born, S.; Bacani, G.; Olson, E. E.; Kobayashi, Y. Synlett 2008, 2877.
7. Burke, J. P.; Sabat, M.; Iovan, D.; Myers, W. H.; Chruma, J. J. Org. Lett. 2010, 12,
3192.
8. For previous total syntheses of 1, see Refs. 5a, 5c and: Varseev, G. N.; Maier, M.
E. Angew. Chem., Int. Ed. 2006, 45, 4767.
At first, n-BuLi (1.6 M in hexane, 1.0 mL, 1.58 mmol) was added
dropwise to a solution of diphenyldiselenide (492 mg, 1.58 mmol)
in THF (3 mL) at ꢀ20 °C. After 20 min, the solution was cooled to
ꢀ78 °C and a solution of aldehyde 10 (273 mg, 1.05 mmol) and d-
pentenolide (ꢀ)-9 (118 mg, 1.05 mmol) in THF (3 mL) was added.
The reaction mixture was kept at ꢀ78 °C for 3 h followed by 16 h
at ꢀ20 °C. The reaction was then quenched with satd NH4Cl
(10 mL), extracted with EtOAc (3 ꢂ 10 mL), and dried (MgSO4).
The concentrated residue was passed through a silica gel column
(50% EtOAc/Hex) to give 15 as a yellow oil and as an inseparable
9. In his studies toward the cytochalasins, E. J. Thomas regularly employed IMDA
reactions involving a-acyl-a,b-unsaturated-c-lactams as dienophiles. The endo